How Will the Next-Generation Antibody Therapeutics Market Grow? Key Trends and Opportunities for 2025 and Beyond
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How Will the Next-Generation Antibody Therapeutics Market Grow Over the Forecast Period Based on Its Expected CAGR?
The next-generation antibody therapeutics market has expanded rapidly in recent years. It is forecasted to increase from $6.82 billion in 2024 to $7.63 billion in 2025, at a CAGR of 11.8%. This market’s historical growth has been attributed to the success of monoclonal antibodies, the rising prevalence of chronic diseases, approval of antibody-drug conjugates, the growth of immunotherapy, and advancements in gene therapy.
The next-generation antibody therapeutics market is projected to grow rapidly, reaching $11.52 billion by 2029 at a CAGR of 10.9%. Growth drivers include the development of biosimilars, advancements in bispecific and nanobody antibodies, patient-centric treatment approaches, immunomodulatory antibody innovations, expanded use in autoimmune diseases, and continuous manufacturing improvements. Key trends will include progress in antibody engineering, digital technologies for antibody design, industry partnerships, advancements in drug delivery systems, and the utilization of real-world evidence in antibody development.
How Are the key drivers Contributing to the Expansion of the next-generation antibody therapeutics Market?
The rising prevalence of chronic diseases is expected to propel the growth of the next-generation antibody therapeutics market. Chronic diseases require long-term care, and next-generation antibody therapeutics provide focused care for chronic illness patients. The National Center for Biotechnology Information (NCBI) projected in January 2023 that by 2050, 142.66 million individuals aged 50 and older in the US will have at least one chronic illness, a 99.5% increase. This increasing prevalence of chronic diseases is driving the next-generation antibody therapeutics market.
Get Your Free Sample of the Global Next-Generation Antibody Therapeutics Market Report Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12678&type=smp
Who Are the Dominant Players Expanding Their Reach in the Next-Generation Antibody Therapeutics Market?
Major companies operating in the next-generation antibody therapeutics market include:
• Pfizer Inc._x000D_
• F. Hoffmann-La Roche Ltd._x000D_
• Bayer AG_x000D_
• Bristol-Myers Squibb Company_x000D_
• AstraZeneca plc_x000D_
What Are the Top Trends Shaping the Evolution of the Next-Generation Antibody Therapeutics Market?
Technological advancements are driving innovation in the next-generation antibody therapeutics market. Companies in this space are focusing on technologies like Molecular Indexing of Proteins by Self-Assembly (MIPSA) to enhance protein analysis, improve therapeutic profiles, and target complex diseases more precisely. For instance, in January 2024, Infinity Bio, Inc., a US-based biotechnology company, launched a next-generation antibody profiling platform using MIPSA technology. This platform provides high-throughput, cost-effective analysis of immune responses to enhance disease understanding and personalize treatment strategies.
Get Instant Access to the Global Next-Generation Antibody Therapeutics Market Report with Swift Delivery!
Which Key Market Segments Comprise the Next-Generation Antibody Therapeutics Market and Drive Its Revenue Growth?
The next-generation antibody therapeutics market covered in this report is segmented –
1) By Types Of Antibodies: Monoclonal Antibodies, Polyclonal Antibodies, Biospecific Antibodies, Antibody-Drug Conjugates, Other Types
2) By Therapeutic Area: Oncology, Autoimmune Diseases, Infectious Diseases, Neurodegenerative Disorders, Other Therapeutic Areas
3) By End-User: Hospitals And Clinics, Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users
Subsegments:
1) By Monoclonal Antibodies: IgG Monoclonal Antibodies, IgM Monoclonal Antibodies
2) By Polyclonal Antibodies: Serum-Derived Polyclonal Antibodies, Hybridoma-Derived Polyclonal Antibodies
3) By Bispecific Antibodies: Dual-Targeting Antibodies, Single-Chain Variable Fragment (scFv) Antibodies
4) By Antibody-Drug Conjugates (ADCs): Targeted ADCs, Payload Types
5) By Other Types: Nanobodies, Engineered Antibodies
Which Regions Are Setting the Pace for Next-Generation Antibody Therapeutics Market Growth?
North America was the largest region in the next-generation antibody therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the next-generation antibody therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What Are the Defining Features of the Next-Generation Antibody Therapeutics Market?
Next-generation antibody therapeutics are advanced antibody-based drugs in structure, functionality, and therapeutic potential beyond traditional monoclonal antibodies. It treats several severe medical problems, including cancer, infectious infections, and immunological disorders.
Browse Through More Similar Reports By The Business Research Company:
Next-Generation Data Storage Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/next-generation-data-storage-global-market-report
Antisense & RNAi Therapeutics Global Market Report 2024
Antibody Drug Conjugates Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/antibody-drug-conjugates-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
